Major U.S. equities indexes slipped lower on Tuesday ahead of Wednesday morning’s Consumer Price Index (CPI) report, a key gauge of inflation that could influence next week’s interest rate decision by the Federal Reserve.
The S&P 500 and the Nasdaq both ended Tuesday’s session around 0.3% lower, while the Dow lost around 0.4%.
Moderna (MRNA) shares plunged 9.1%, losing the most of any S&P 500 stock after Bank of America reinitiated coverage of the biotech stock with an “underperform” rating. Analysts pointed to the pharmacy maker’s elevated levels of research and development (R&D) spending and uncertainty about the true value of Moderna’s pipeline. They also said the financial impact of Moderna’s respiratory syncytial virus (RSV) vaccine will likely remain limited.
Shares of server and data storage provider Super Micro Computer (SMCI) fell 8.2%. Late last week, the Nasdaq extended Supermicro’s filing deadline until February 2025 for its delayed annual report. Although the CEO expressed confidence …